Article
Immunobiotherapy directed against mutated and aberrantly expressed gene products in pancreas cancer.
Journal of cellular biochemistry - 15 Apr 2005
Plate Janet M D, Harris Jules E
Abstract excerpt
Genetic alterations are responsible for the development of cancer in ductal cells of the pancreas. These genetic changes result in abnormal molecular expression of proteins that are involved in cell proliferation, cell cycle control and adhesion. Some of the genetic mutations result in aberrant proteins that can be recognized as novel or foreign by cells of innate and adaptive immune systems. These are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
